Reshma Rangwala, EVP & Chief Medical Officer: Karyopharm Therapeutics KPTI Sell · Filed 24/04/23

Trade details

Type: Insider sale
Amount: $7,943.13
Shares · price: 6,789 sh · $1.17 a share
Held after: 342,931 sh
Stock: Karyopharm Therapeutics KPTI
Person: Reshma RangwalaEVP & Chief Medical Officer
Trade date: 24/04/22
Filed: 24/04/23
Days to filing: 1 days

Sold 1.9% of holdings

Share of holding sold: 1.9%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/23~24/05/22

Reshma Rangwala's recent trades

Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,876
408 sh
$3,876
Filed 05/15
Traded 05/14
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$4,014
449 sh
$4,014
Filed 04/22
Traded 04/21
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$47.7K
5,066 sh
$47.7K
Filed 03/03
Traded 03/02
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,623
408 sh
$2,623
Filed 25/09/16
Traded 25/09/15
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,585
419 sh
$2,585
Filed 25/04/24
Traded 25/04/23

Reshma Rangwala, Chief Officer — sold $7,943 of Karyopharm Therapeutics KPTI · 1.9% of holdings | Whalegun